GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class New kit offers researchers and development teams a meaningful advance in expression speed and output May 12, 2026 BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a next-generation antibody expression reagent designed to set a new benchmark for speed, performance, output and ease-of-use. One of the company's largest global product launches to date, this kit targets the fast-growing expression reagent market, driven by high-throughput and AI-enabled research. Introducing the TurboCHO™ Protein Expression Kit, a launchpad in every kit. Producing research-grade antibodies and proteins is a foundational step in drug discovery and biologics development. The new kit brings GenScript's proven protein-expression technology directly to the bench in a ready-to-use format, enabling labs of any size to generate high‑quality protein in as little as five business days. As a result, researchers can access reliable…